Not only do patients have no idea about the actual prices of their prescriptions, but their doctors don’t either.

Brand-name pharmaceutical companies are convincing consumers to keep using products that cost insurance companies far more than generic equivalents.

New products approved by the Food and Drug Administration can make a lot of money. Maybe the cash-strapped agency should get a percentage.

Put the money toward research, treatment and finding ways to better the health of everyone, the same as we did with tobacco settlements.

All of the choices now available to Medicare recipients could live on, even in a single-payer system.

The U.S. government and pharmaceutical companies can’t seem to solve the problem, but some creative work-arounds are taking shape.

Its a multibillion-dollar industry, but do all those products do what they claim? Consumers have no way of knowing.

When you get your medicine by mail order, you lose the chance to have a convenient consultation about what you’re taking.

New federal rules require medical facilities to post spreadsheets itemizing their charges. Computers can read them, but people can’t.

Medical aid in dying is only an option for those with six months or less to live, but even still-healthy people may want to know how the new law could apply to them.

The U.S. takes forever to approve drugs before they can be sold to the public, but no such caution is taken with new devices.

Big companies are self-insuring themselves and taking other steps to control medical costs. Is this a return to plantation days?